Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Olympia Kouliou"'
Autor:
Maria A. Kyritsi, Matthaios Speletas, Varvara Mouchtouri, Evangelia Vachtsioli, Dimitrios Babalis, Olympia Kouliou, Anastasia Tsispara, Maria Tseroni, Christos Hadjichristodoulou
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1048 (2022)
Due to the prevailing ambiguity regarding the performance of rapid antigen tests (RATs) for B.1.1.529 (Omicron) variant diagnosis, a commercial RAT was evaluated in the emergency ward of a general hospital in Larissa, Central Greece. The sampling and
Externí odkaz:
https://doaj.org/article/ed84d8e3d7c64b7c8349f054f7ca9452
Autor:
Eleftherios Papazoglou, Rajesh Jagirdar, Chrissi Hatzoglou, Olympia Kouliou, Eleanna Pitaraki, Konstantinos I. Gourgoulianis, Irini Gerogianni, Sotirios G. Zarogiannis, Stefanos Giannopoulos, Lydia Giannakou
Publikováno v:
Anticancer Research. 39:3809-3814
BACKGROUND/AIM Malignant pleural mesothelioma (MPM) is a therapy-resistant neoplasm of the pleura. Standard chemotherapy consists of a combination of cisplatin (CPDD) and pemetrexed (PEM). The aim of this study was to assess whether inhibition of aer
Autor:
Stefanos Giannopoulos, Eleftherios Papazoglou, Lydia Giannakou, Eleanna Pitaraki, Konstantinos I. Gourgoulianis, Sotirios G. Zarogiannis, Olympia Kouliou, Chrissi Hatzoglou, Erasmia Rouka, Rajesh Jagirdar, Sotirios I. Sinis
Publikováno v:
Clinical and experimental pharmacologyphysiologyREFERENCES. 48(4)
Malignant pleural mesothelioma (MPM) is an aggressive tumour that grows in the pleural cavity. MPM spheroids released in the pleural fluid can form new tumour foci. Cell-cell, cell-extracellular matrix (ECM) interactions in 2D and 3D impact malignant
Autor:
Eleanna Pitaraki, Chrissi Hatzoglou, Rajesh Jagirdar, Olympia Kouliou, Sotiris Zarogiannis, Konstandinos Gourgouliannis, Irene Gerogianni
Publikováno v:
Pleural and mediastinal malignancies.
Introduction: Metabolic adaptations favor survival of cancer cells with higher glucose uptake. 2-Deoxy-glucose (2DG), a mimetic of glucose cannot undergo further glycolysis and hampers cell growth, essential during tumor metabolism. Chemotherapy with
Autor:
Sotiris Zaroginannis, Rajesh Jagirdar, Chrissi Hatzoglou, Konstantinos I. Gourgoulianis, Irene Gerogianni, Eleanna Pitaraki, Olympia Kouliou
Publikováno v:
Pleural and mediastinal malignancies.
Autor:
Rajesh Jagirdar, Chrissi Hatzoglou, Olympia Kouliou, Sotirios G. Zarogiannis, Konstantinos I. Gourgoulianis, Eleanna Pitaraki, Eleftherios Papazoglou
Publikováno v:
Cancers
Volume 11
Issue 10
Cancers, Vol 11, Iss 10, p 1446 (2019)
Volume 11
Issue 10
Cancers, Vol 11, Iss 10, p 1446 (2019)
Malignant pleural mesothelioma (MPM) is an aggressive cancer with poor prognosis. The main treatment for MPM is doublet chemotherapy with Cisplatin and Pemetrexed, while ongoing trials test the efficacy of pemetrexed monotherapy. However, there is la